| | | Single nucleotide variant (missense variant +2 more) | Tietz syndrome +2 more | |
| | | Duplication (intron variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (nonsense +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Deletion (intron variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Deletion (intron variant) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +2 more | |
| | | Deletion (frameshift variant) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (synonymous variant) | Tietz syndrome +6 more | |
| | | Single nucleotide variant (synonymous variant) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +4 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +4 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +3 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (nonsense +1 more) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | MITF-related condition +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Tietz syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Waardenburg syndrome type 2A +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +4 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Tietz syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Tietz syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (intron variant) | MITF-related condition +3 more | |
| | | Microsatellite (intron variant) | Tietz syndrome +2 more | |
| | | Microsatellite (intron variant) | Waardenburg syndrome type 2A +2 more | |
| | | Deletion (intron variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (intron variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | MITF-related condition +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (intron variant) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 8 +2 more | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +4 more | |
| | | Single nucleotide variant (missense variant) | MITF-related condition +5 more | |
| | | Single nucleotide variant (synonymous variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (synonymous variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Waardenburg syndrome type 2A +2 more | |
| | | Single nucleotide variant (missense variant) | Tietz syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Microsatellite (frameshift variant) | Tietz syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | not specified +4 more | |
| | | Single nucleotide variant (synonymous variant) | Tietz syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Waardenburg syndrome type 2A +3 more | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense) | not provided +3 more | GPathogenic/Likely pathogenic |